Anterior ST-elevation myocardial infarction in the very elderly: does anatomy still matter? [0.03%]
老年人前壁急性心肌梗死，解剖结构还重要吗？
Marco Spagnolo,Davide Capodanno
Marco Spagnolo
Impact of left anterior descending lesions on 30-day mortality in very elderly STEMI patients: insights from a multicenter registry [0.03%]
左前降支病变对极高龄STEMI患者30天死亡率的影响——来自一个多中心注册研究的启示
Andrea Agbariah,Alessandro Ruzzarin,Filippo Zilio et al.
Andrea Agbariah et al.
Aims: ST-elevation myocardial infarction (STEMI) in very elderly patients (≥85 years) poses a major clinical challenge due to frailty and comorbidities. In the general population, left anterior descending (LAD) artery in...
Long-term clinical outcomes of TAVI in hospitals without on-site cardiac surgery: insights from the MURGIA-TAVI Registry [0.03%]
经导管主动脉瓣植入术无现场心脏手术医院的长期临床结果：MURGIA-TAVI登记处的研究见解
Giandomenico Mancini,Maria Scarcia,Eloisa Basile et al.
Giandomenico Mancini et al.
Aims: Transcatheter aortic valve implantation (TAVI) is the standard of care for elderly (≥70 years) or high-risk patients with severe aortic stenosis, yet current guidelines recommend its performance only in Heart Valve...
Safety and efficacy of transcatheter aortic valve replacement for native pure aortic valve regurgitation [0.03%]
经导管主动脉瓣置换治疗单纯性主动脉瓣反流的的安全性和有效性研究
Giulio Giovanni Cavalli,Albino Vallabini,Maurizio Braccio et al.
Giulio Giovanni Cavalli et al.
Aims: Transcatheter aortic valve replacement has become the standard of care for high-risk patients with aortic stenosis. Considering the unique procedural challenges posed by native pure aortic regurgitation (NPAR), our ...
Coping with recurrent pericarditis: bridging guidelines and clinical practice [0.03%]
反复发作性心包炎的治疗：指南与临床实践之间的联系
Massimo Imazio,Mariacristina Tomat,Francesco Venturelli et al.
Massimo Imazio et al.
Robustness of highly purified eicosapentaenoic acid trials and their cardiovascular outcomes [0.03%]
高纯度二十碳五烯酸试验的稳健性及其心血管结局
Marco Zuin,Claudio Bilato
Marco Zuin
Aims: Despite contemporary statin therapy, patients with atherosclerotic cardiovascular disease or high cardiovascular risk experience a residual risk of major adverse events. Eicosapentaenoic acid (EPA) has been evaluate...
Severe pericardial effusion as the initial manifestation of diffuse large B-cell lymphoma [0.03%]
弥漫性大B细胞淋巴瘤的初始表现为严重心包积液
Matteo Brusamolino,Giorgio Agati,Flavia Nicoli et al.
Matteo Brusamolino et al.
The effect of intravenous sodium ferric gluconate complex (Ferrlecit) on outcomes of patients undergoing transcatheter aortic valve implantation: a prospective randomized controlled trial [0.03%]
静脉铁葡萄糖酸钠复合物（Ferrlecit）对经导管主动脉瓣植入术患者结局影响的前瞻性随机对照试验
Omer Bar,Robert Zukerman,Basheer Halhal et al.
Omer Bar et al.
Aims: The aim of this trial was to evaluate whether intravenous sodium ferric gluconate could provide benefit beyond transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis. ...
Improved endothelial function in heart failure outpatients with reduced ejection fraction after vericiguat therapy [0.03%]
用于射血分数降低的心力衰竭门诊患者的维司力奇治疗后内皮功能改善
Michele Correale,Federica Santagata,Damiano D&#x;Alessandro et al.
Michele Correale et al.
Background: Vericiguat, a soluble guanylate cyclase stimulator, has been shown to be effective in improving the prognosis of patients with heart failure with reduced ejection fraction (HFrEF) and worsening heart failure. ...